Veterinary medicinal products are intended for use in treating, mitigating, or preventing illnesses or to influence specific body functions in animals. Considerable amounts of these medicinal products enter the environment via animal excrements, livestock manure, waste water, and other farm waste especially from intensive fattening operations.
People are alarmed by the growing contamination of surface and ground water, soil, and food with pharmaceutical residues. It is apparent that measures are needed to enhance the protection of the environment from the adverse effects of pharmaceutical pollution on various levels – from preventive measures on farm level, to the introduction of binding limits for active pharmaceutical ingredients in groundwater and in surface water, to more environmental protection in pharmaceutical approval and regulations for use.
The European Framework Directive 2001/82/EG regulates the production, placing on the market, labelling, marketing, and use of veterinary pharmaceuticals in the European Union. This Directive is actually being revised. On the backdrop of environmental burdens related to veterinary medicinal products and the increase of antimicrobial resistance and in the interests of preventive environmental protection, PAN Germany’s position is that this revision should enhance the protection of the environment and consumers and animal welfare.
The European Union has committed itself to the protection of its natural resources; environmen-tal protection is anchored in the goals of the European Union Animal Health Strategy . In PAN Germany's opinion, the implementation of the following demands can contribute to reduce the existing deficits and to achieving the umbrella goals of the European Union, such as sustainable use of natural resources, the protection of biodiversity and water, consumer protection, and the protection of human and animal health.
© 2018 PAN Germany Seitenanfang PAN Germany, E-Mailvalidieren